CRMP4-mediated fornix development involves semaphorin-3E signaling pathway

  1. Benoît Boulan
  2. Charlotte Ravanello
  3. Amandine Peyrel
  4. Christophe Bosc
  5. Christian Delphin
  6. Florence Appaix
  7. Eric Denarier
  8. Alexandra Kraut
  9. Muriel Jacquier-Sarlin
  10. Alyson Fournier
  11. Annie Andrieux
  12. Sylvie Gory-Fauré  Is a corresponding author
  13. Jean-Christophe Deloulme  Is a corresponding author
  1. Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, France
  2. Univ. Grenoble Alpes, INSERM, CEA, UMR BioSanté U1292, CNRS, CEA, France
  3. McGill University, Canada

Abstract

Neurodevelopmental axonal pathfinding plays a central role in correct brain wiring and subsequent cognitive abilities. Within the growth cone, various intracellular effectors transduce axonal guidance signals by remodeling the cytoskeleton. Semaphorin-3E (Sema3E) is a guidance cue implicated in development of the fornix, a neuronal tract connecting the hippocampus to the hypothalamus. Microtubule-Associated Protein 6 (MAP6) has been shown to be involved in the Sema3E growth-promoting signaling pathway. In this study, we identified the Collapsin Response Mediator Protein 4 (CRMP4) as a MAP6 partner and a crucial effector in Sema3E growth-promoting activity. CRMP4-KO mice displayed abnormal fornix development reminiscent of that observed in Sema3E-KO mice. CRMP4 was shown to interact with the Sema3E tripartite receptor complex within Detergent-Resistant Membrane (DRM) domains, and DRM domain integrity was required to transduce Sema3E signaling through the Akt/GSK3 pathway. Finally, we showed that the cytoskeleton-binding domain of CRMP4 is required for Sema3E's growth-promoting activity, suggesting that CRMP4 plays a role at the interface between Sema3E receptors, located in DRM domains, and the cytoskeleton network. As the fornix is affected in many psychiatric diseases, such as schizophrenia, our results provide new insights to better understand the neurodevelopmental components of these diseases.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 2, Figure 4, Figure 5, Figure 6 , Figure 7, Figure 8, Figure 9, Figure 10 and supplementary File 1

Article and author information

Author details

  1. Benoît Boulan

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6793-5378
  2. Charlotte Ravanello

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Amandine Peyrel

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Christophe Bosc

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Christian Delphin

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Florence Appaix

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Eric Denarier

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4169-397X
  8. Alexandra Kraut

    Univ. Grenoble Alpes, INSERM, CEA, UMR BioSanté U1292, CNRS, CEA, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Muriel Jacquier-Sarlin

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8501-7511
  10. Alyson Fournier

    Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  11. Annie Andrieux

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4022-6405
  12. Sylvie Gory-Fauré

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    For correspondence
    sylvie.gory-faure@univ-grenoble-alpes.fr
    Competing interests
    The authors declare that no competing interests exist.
  13. Jean-Christophe Deloulme

    Univ. Grenoble Alpes, Inserm, U1216, CEA, Grenoble Institut Neurosciences, Grenoble, France
    For correspondence
    Jean-Christophe.deloulme@univ-grenoble-alpes.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2234-5865

Funding

Agence Nationale de la Recherche (2010- Blanc-120201 CBioS)

  • Christophe Bosc

Agence Nationale de la Recherche (2017-CE11-0026 MAMAs)

  • Annie Andrieux

The funder had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Fadel Tissir, Université Catholique de Louvain, Belgium

Ethics

Animal experimentation: The study protocol was approved by the local animal welfare committee (Comité Local GIN, C2EA-04 - APAFIS number 8303-2016060110523424) and complied with EU guidelines (directive 2010/63/EU). Every precaution was taken to minimize the number of animals used and stress to animals during experiments.

Version history

  1. Received: May 14, 2021
  2. Accepted: December 2, 2021
  3. Accepted Manuscript published: December 3, 2021 (version 1)
  4. Accepted Manuscript updated: December 6, 2021 (version 2)
  5. Accepted Manuscript updated: December 6, 2021 (version 3)
  6. Accepted Manuscript updated: December 13, 2021 (version 4)
  7. Version of Record published: December 17, 2021 (version 5)
  8. Version of Record updated: December 20, 2021 (version 6)

Copyright

© 2021, Boulan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 802
    Page views
  • 132
    Downloads
  • 2
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Benoît Boulan
  2. Charlotte Ravanello
  3. Amandine Peyrel
  4. Christophe Bosc
  5. Christian Delphin
  6. Florence Appaix
  7. Eric Denarier
  8. Alexandra Kraut
  9. Muriel Jacquier-Sarlin
  10. Alyson Fournier
  11. Annie Andrieux
  12. Sylvie Gory-Fauré
  13. Jean-Christophe Deloulme
(2021)
CRMP4-mediated fornix development involves semaphorin-3E signaling pathway
eLife 10:e70361.
https://doi.org/10.7554/eLife.70361

Share this article

https://doi.org/10.7554/eLife.70361

Further reading

    1. Developmental Biology
    2. Neuroscience
    Tariq Zaman, Daniel Vogt ... Michael R Williams
    Research Article

    The cell-type-specific expression of ligand/receptor and cell-adhesion molecules is a fundamental mechanism through which neurons regulate connectivity. Here, we determine a functional relevance of the long-established mutually exclusive expression of the receptor tyrosine kinase Kit and the trans-membrane protein Kit Ligand by discrete populations of neurons in the mammalian brain. Kit is enriched in molecular layer interneurons (MLIs) of the cerebellar cortex (i.e., stellate and basket cells), while cerebellar Kit Ligand is selectively expressed by a target of their inhibition, Purkinje cells (PCs). By in vivo genetic manipulation spanning embryonic development through adulthood, we demonstrate that PC Kit Ligand and MLI Kit are required for, and capable of driving changes in, the inhibition of PCs. Collectively, these works in mice demonstrate that the Kit Ligand/Kit receptor dyad sustains mammalian central synapse function and suggest a rationale for the affiliation of Kit mutation with neurodevelopmental disorders.

    1. Developmental Biology
    2. Neuroscience
    Smrithi Prem, Bharati Dev ... Emanuel DiCicco-Bloom
    Research Article

    Autism spectrum disorder (ASD) is defined by common behavioral characteristics, raising the possibility of shared pathogenic mechanisms. Yet, vast clinical and etiological heterogeneity suggests personalized phenotypes. Surprisingly, our iPSC studies find that six individuals from two distinct ASD-subtypes, idiopathic and 16p11.2 deletion, have common reductions in neural precursor cell (NPC) neurite outgrowth and migration even though whole genome sequencing demonstrates no genetic overlap between the datasets. To identify signaling differences that may contribute to these developmental defects, an unbiased phospho-(p)-proteome screen was performed. Surprisingly despite the genetic heterogeneity, hundreds of shared p-peptides were identified between autism subtypes including the mTOR pathway. mTOR signaling alterations were confirmed in all NPCs across both ASD-subtypes, and mTOR modulation rescued ASD phenotypes and reproduced autism NPC associated phenotypes in control NPCs. Thus, our studies demonstrate that genetically distinct ASD subtypes have common defects in neurite outgrowth and migration which are driven by the shared pathogenic mechanism of mTOR signaling dysregulation.